Nutex Health Inc. (NASDAQ:NUTX) Shares Acquired by Baader Bank Aktiengesellschaft

Key Points

• Baader Bank Aktiengesellschaft increased its stake in Nutex Health Inc. by 64.6% in Q1, owning 10,700 shares valued at $503,000.
• Nutex Health reported an earnings per share of $2.56, significantly surpassing analyst estimates of ($0.15), with revenue reaching $211.79 million for the quarter.
• Research firms have raised their price targets for Nutex Health, with Maxim Group setting a new target of $225.00 and Benchmark raising theirs to $300.00, both maintaining a "buy" rating.

Baader Bank Aktiengesellschaft raised its holdings in Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 64.6% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 10,700 shares of the company's stock after acquiring an additional 4,200 shares during the quarter. Baader Bank Aktiengesellschaft owned 0.19% of Nutex Health worth $503,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Bank of America Corp DE increased its position in shares of Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares in the last quarter. Northern Trust Corp purchased a new position in shares of Nutex Health in the fourth quarter valued at $200,000. Millennium Management LLC purchased a new position in shares of Nutex Health in the fourth quarter valued at $213,000. World Investment Advisors purchased a new position in shares of Nutex Health in the fourth quarter valued at $217,000. Finally, OMERS ADMINISTRATION Corp purchased a new position in shares of Nutex Health in the fourth quarter valued at $231,000. Institutional investors and hedge funds own 5.32% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Wall Street Zen cut Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd. Benchmark lifted their price objective on Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research report on Thursday, May 15th. Finally, Maxim Group lifted their price objective on Nutex Health from $100.00 to $225.00 and gave the stock a "buy" rating in a research report on Tuesday, May 20th.

Nutex Health Trading Up 6.3%

NASDAQ:NUTX traded up $5.29 during mid-day trading on Monday, reaching $89.29. The company's stock had a trading volume of 56,339 shares, compared to its average volume of 143,010. The company's fifty day simple moving average is $120.63 and its two-hundred day simple moving average is $97.29. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. Nutex Health Inc. has a twelve month low of $6.45 and a twelve month high of $184.27. The stock has a market cap of $496.42 million, a P/E ratio of 7.51 and a beta of 0.05.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $2.71. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%. The firm had revenue of $211.79 million for the quarter, compared to analyst estimates of $81.09 million.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.